SELLAS Life Sciences Group, Inc.: shareholders and insiders

SLSNASDAQHealthcare · Pharmaceutical Preparations

Price

$17.95

November 18, 2026Market cap $3.7B

What Ploutos Investor adds for SELLAS Life Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 124% since Nov 12, 2026, when the 10-Q these figures come from was filed ($8.03 then, $17.95 on Nov 18, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Jun 18, 2026, from their own Form 4 filings.

1 Form 4s

Bought on the market

$100.8K

1 person

Sold on the market

–

nobody

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Nov 19, 2025Katherine Bach Kalin
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 18, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by SLS's officers and directors from 2009 up to November 18, 2025, 17 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Nov 10, 2026 Latest filing
  • BlackRock, Inc.
    Share of class7.90%
  • Vanguard Capital Management
    Share of class5.19%
  • State Street
    Share of class5.10%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Anson Funds Management LP4.90%Feb 17, 202613G/A
  • Highbridge Capital Management, LLC3.70%Jan 30, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Renaissance Technologies
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter
  • AQR Capital
    In the quarter+7.6%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 26.4% of its shares outstanding were held short, -2.5% since the report before.

Shares held short
53.76M
26.4%
Since the report before55.13M on Sep 30, 2026
-2.5%
12.0
4.50M
More days to cover thanof 4,578 US-listed companies with enough volume
95%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 3.05M
  • Nov 15, 2023: Shares held short 4.58M
  • Nov 30, 2023: Shares held short 4.61M
  • Dec 15, 2023: Shares held short 4.66M
  • Dec 29, 2023: Shares held short 4.73M
  • Jan 12, 2024: Shares held short 3.88M
  • Jan 31, 2024: Shares held short 3.12M
  • Feb 15, 2024: Shares held short 3.89M
  • Feb 29, 2024: Shares held short 4.51M
  • Mar 15, 2024: Shares held short 5.18M
  • Mar 28, 2024: Shares held short 5.27M
  • Apr 15, 2024: Shares held short 5.67M
  • Apr 30, 2024: Shares held short 6.99M
  • May 15, 2024: Shares held short 7.25M
  • May 31, 2024: Shares held short 7.65M
  • Jun 14, 2024: Shares held short 7.55M
  • Jun 28, 2024: Shares held short 8.86M
  • Jul 15, 2024: Shares held short 9.72M
  • Jul 31, 2024: Shares held short 10.65M
  • Aug 15, 2024: Shares held short 7.72M
  • Aug 30, 2024: Shares held short 8.22M
  • Sep 13, 2024: Shares held short 8.16M
  • Sep 30, 2024: Shares held short 8.18M
  • Oct 15, 2024: Shares held short 6.08M
  • Oct 31, 2024: Shares held short 8.61M
  • Nov 15, 2024: Shares held short 8.77M
  • Nov 29, 2024: Shares held short 9.05M
  • Dec 13, 2024: Shares held short 7.46M
  • Dec 31, 2024: Shares held short 7.97M
  • Jan 15, 2025: Shares held short 9.00M
  • Jan 31, 2025: Shares held short 9.81M
  • Feb 14, 2025: Shares held short 8.65M
  • Feb 28, 2025: Shares held short 7.81M
  • Mar 14, 2025: Shares held short 7.85M
  • Mar 31, 2025: Shares held short 8.18M
  • Apr 15, 2025: Shares held short 7.77M
  • Apr 30, 2025: Shares held short 7.71M
  • May 15, 2025: Shares held short 8.76M
  • May 30, 2025: Shares held short 12.22M
  • Jun 13, 2025: Shares held short 18.90M
  • Jun 30, 2025: Shares held short 24.36M
  • Jul 15, 2025: Shares held short 27.74M
  • Jul 31, 2025: Shares held short 26.41M
  • Aug 15, 2025: Shares held short 29.15M
  • Aug 29, 2025: Shares held short 29.34M
  • Sep 15, 2025: Shares held short 20.89M
  • Sep 30, 2025: Shares held short 23.05M
  • Oct 15, 2025: Shares held short 25.09M
  • Oct 31, 2025: Shares held short 28.96M
  • Nov 14, 2025: Shares held short 31.79M
  • Nov 28, 2025: Shares held short 33.26M
  • Dec 15, 2025: Shares held short 40.47M
  • Dec 31, 2025: Shares held short 49.43M
  • Jan 15, 2026: Shares held short 42.04M
  • Jan 30, 2026: Shares held short 41.33M
  • Feb 13, 2026: Shares held short 46.05M
  • Feb 27, 2026: Shares held short 49.13M
  • Mar 13, 2026: Shares held short 45.79M
  • Mar 31, 2026: Shares held short 53.53M
  • Apr 15, 2026: Shares held short 56.64M
  • Apr 30, 2026: Shares held short 57.15M
  • May 15, 2026: Shares held short 57.07M
  • May 29, 2026: Shares held short 61.00M
  • Jun 15, 2026: Shares held short 63.36M
  • Jun 30, 2026: Shares held short 63.31M
  • Jul 15, 2026: Shares held short 55.28M
  • Jul 31, 2026: Shares held short 54.98M
  • Aug 14, 2026: Shares held short 56.37M
  • Aug 31, 2026: Shares held short 57.93M
  • Sep 15, 2026: Shares held short 59.07M
  • Sep 30, 2026: Shares held short 55.13M
  • Oct 15, 2026: Shares held short 53.76M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading56.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 56.9% of the shares in the reported trades were short sales, against 62.6% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
56.9%
The 14 beforeOct 12, 2026 – Oct 29, 2026
62.6%
Change
-5.7 pts
Short sales a dayon average, of 6.81M shares
3.88M
More than atof 3,656 US-listed companies, same days
73%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 61.3%
  • Oct 13, 2026: Short sales 66.6%
  • Oct 14, 2026: Short sales 57.5%
  • Oct 15, 2026: Short sales 57.2%
  • Oct 16, 2026: Short sales 67.1%
  • Oct 19, 2026: Short sales 60.6%
  • Oct 20, 2026: Short sales 51%
  • Oct 21, 2026: Short sales 57.6%
  • Oct 22, 2026: Short sales 61.2%
  • Oct 23, 2026: Short sales 60.8%
  • Oct 26, 2026: Short sales 59.2%
  • Oct 27, 2026: Short sales 46.2%
  • Oct 28, 2026: Short sales 73.9%
  • Oct 29, 2026: Short sales 59.4%
  • Oct 30, 2026: Short sales 59.6%
  • Nov 2, 2026: Short sales 49.1%
  • Nov 3, 2026: Short sales 62.1%
  • Nov 4, 2026: Short sales 51.5%
  • Nov 5, 2026: Short sales 56%
  • Nov 6, 2026: Short sales 51.1%
  • Nov 9, 2026: Short sales 57.5%
  • Nov 10, 2026: Short sales 55%
  • Nov 11, 2026: Short sales 53.7%
  • Nov 12, 2026: Short sales 62.7%
  • Nov 13, 2026: Short sales 69.3%
  • Nov 16, 2026: Short sales 63.4%
  • Nov 17, 2026: Short sales 53.9%
  • Nov 18, 2026: Short sales 63.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

1.91M Insiders' shares1.07% Of the company
  • Angelos M. StergiouPresident and CEO
    Directly1.76M
  • Katherine Bach KalinDirector
    Directly104.4K
  • Jane WasmanDirector
    Directly30.4K
  • Nostrand Robert L VanDirector
    Directly20.4K

A lower bound: it counts only the 4 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

12 ETFs holding it1.19% The largest weight (XBI)
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund1.19%
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.61%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.59%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.17%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.09%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.08%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.03%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.03%
  • ONEQFidelity Nasdaq Composite Index ETF
    Weight in the fund0.01%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%

12 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

192 Managers, Q2 2026$1.1B Value of their positions
  • Q3 2025: Managers 94
  • Q4 2025: Managers 112
  • Q1 2026: Managers 161
  • Q2 2026: Managers 192

Institutional investors by quarter

The fund managers holding SLS, quarter by quarter, from Q1 2016 to Q2 2025, 31 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 192 managers held 73.75M shares, worth $1.1B. During the quarter 61 opened a position, 32 closed one, 75 added and 25 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+24%
  • State Street
    In the quarter+55%
  • Vanguard Capital Management
    In the quarter+9.3%
  • Geode Capital Management
    In the quarter+25%
  • Anson Funds Management
    In the quarter
  • Jones Financial Companies Lllp
    In the quarter+38%
  • Vanguard Portfolio Management
    In the quarter+48%
  • Susquehanna International Group
    In the quarter+416%
  • Northern Trust
    In the quarter+27%
  • Vanguard Fiduciary Trust
    In the quarter+11%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do SELLAS Life Sciences's filings show?

Who buys and sells is one part of SELLAS Life Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SLS's shareholders

Didn't find what you were looking for?

Ask us
Have SLS's insiders bought or sold?

From Jun 18, 2026 to Jun 18, 2026 SELLAS Life Sciences's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold SLS?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $900.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.